67 related articles for article (PubMed ID: 9601498)
1. Characterization of age- and dose-related outcomes of duck hepatitis B virus infection.
Jilbert AR; Botten JA; Miller DS; Bertram EM; Hall PM; Kotlarski J; Burrell CJ
Virology; 1998 May; 244(2):273-82. PubMed ID: 9601498
[TBL] [Abstract][Full Text] [Related]
2. Entecavir therapy combined with DNA vaccination for persistent duck hepatitis B virus infection.
Foster WK; Miller DS; Marion PL; Colonno RJ; Kotlarski I; Jilbert AR
Antimicrob Agents Chemother; 2003 Aug; 47(8):2624-35. PubMed ID: 12878529
[TBL] [Abstract][Full Text] [Related]
3. Detection of duck hepatitis B virus DNA on filter paper by PCR and SYBR green dye-based quantitative PCR.
Wang CY; Giambrone JJ; Smith BF
J Clin Microbiol; 2002 Jul; 40(7):2584-90. PubMed ID: 12089280
[TBL] [Abstract][Full Text] [Related]
4. Superinfection exclusion in duck hepatitis B virus infection is mediated by the large surface antigen.
Walters KA; Joyce MA; Addison WR; Fischer KP; Tyrrell DL
J Virol; 2004 Aug; 78(15):7925-37. PubMed ID: 15254165
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of duck hepatitis B virus replication by 9-(2-phosphonylmethoxyethyl)adenine, an acyclic phosphonate nucleoside analogue.
Nicoll AJ; Colledge DL; Toole JJ; Angus PW; Smallwood RA; Locarnini SA
Antimicrob Agents Chemother; 1998 Dec; 42(12):3130-5. PubMed ID: 9835503
[TBL] [Abstract][Full Text] [Related]
6. Anti-HBV effect of liposome-encapsulated matrine in vitro and in vivo.
Li CQ; Zhu YT; Zhang FX; Fu LC; Li XH; Cheng Y; Li XY
World J Gastroenterol; 2005 Jan; 11(3):426-8. PubMed ID: 15637760
[TBL] [Abstract][Full Text] [Related]
7. An in vivo duck hepatitis B virus model recapitulates key aspects of nucleic acid polymer treatment outcomes in chronic hepatitis B patients.
Debing Y; Vanrusselt H; Degrauwe L; Silva de Oliveira DA; Kariuki CK; Ebwanga EJ; Bashir S; Merckx W; Thatikonda SK; Rajwanshi V; Gohil V; Hong J; Kum DB; Acosta Sanchez A; Chanda S; Blatt LM; Jekle A; Symons JA; Smith DB; Raboisson P; Lin TI; Beigelman L; Paeshuyse J
Antiviral Res; 2024 Apr; 224():105835. PubMed ID: 38401714
[TBL] [Abstract][Full Text] [Related]
8. Genetic characterization of duck hepatitis B viruses from Anhui Province, China.
Ye Y; Wang Y; Li H; Liu Y; Meng C; Zhu J; Liu G; Li C
Braz J Microbiol; 2023 Dec; 54(4):3299-3305. PubMed ID: 37673839
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a hydrodynamic delivery system in ducks.
Zhao Z; Zhu J; Zhou L; Sun N; Chang K; Hu X; Hu Y; Ren M; Cheng Y; Xu D; Xin H; Zhang C
Transgenic Res; 2024 Apr; 33(1-2):35-46. PubMed ID: 38461212
[TBL] [Abstract][Full Text] [Related]
10. Does limited virucidal activity of biocides include duck hepatitis B virucidal action?
Sauerbrei A; Schacke M; Glück B; Bust U; Rabenau HF; Wutzler P
BMC Infect Dis; 2012 Oct; 12():276. PubMed ID: 23110658
[TBL] [Abstract][Full Text] [Related]
11. Animal models and the molecular biology of hepadnavirus infection.
Mason WS
Cold Spring Harb Perspect Med; 2015 Apr; 5(4):. PubMed ID: 25833941
[TBL] [Abstract][Full Text] [Related]
12. Molecular Detection and Genetic Characterization of Vertically Transmitted Viruses in Ducks.
Wang X; Yu H; Zhang W; Fu L; Wang Y
Animals (Basel); 2023 Dec; 14(1):. PubMed ID: 38200736
[TBL] [Abstract][Full Text] [Related]
13. The Development of a Multienzyme Isothermal Rapid Amplification Assay to Visually Detect Duck Hepatitis B Virus.
Xu S; Man Y; Xu X; Ji J; Wang Y; Yao L; Xie Q; Bi Y
Vet Sci; 2024 Apr; 11(5):. PubMed ID: 38787163
[TBL] [Abstract][Full Text] [Related]
14. Slowly folding surface extension in the prototypic avian hepatitis B virus capsid governs stability.
Makbul C; Nassal M; Böttcher B
Elife; 2020 Aug; 9():. PubMed ID: 32795390
[TBL] [Abstract][Full Text] [Related]
15. Genetic diversity and phylogeographic dynamics of avihepadnavirus: a comprehensive full-length genomic view.
Sikandar M; Shah PT; Xing L
Front Vet Sci; 2024; 11():1385033. PubMed ID: 38756526
[TBL] [Abstract][Full Text] [Related]
16. Modeling Hepatotropic Viral Infections: Cells vs. Animals.
Khoshdel-Rad N; Zahmatkesh E; Bikmulina P; Peshkova M; Kosheleva N; Bezrukov EA; Sukhanov RB; Solovieva A; Shpichka A; Timashev P; Vosough M
Cells; 2021 Jul; 10(7):. PubMed ID: 34359899
[TBL] [Abstract][Full Text] [Related]
17. Correction: Interleukin-22 facilitates the interferon-λ-mediated production of tripartite motif protein 25 to inhibit replication of duck viral hepatitis A virus type 1.
An H; Liu Y; Shu M; Chen J
Vet Res; 2024 Apr; 55(1):47. PubMed ID: 38594771
[No Abstract] [Full Text] [Related]
18. Attenuation of Avian Flavivirus by Rewiring the Leucine and Serine Codons of Its E-NS1 Protein toward Stop Mutation To Redirect Virus Evolution.
Guo J; He Y; Wang X; Merits A; Wang M; Jia R; Zhu D; Liu M; Zhao X; Yang Q; Wu Y; Zhang S; Huang J; Mao S; Ou X; Gao Q; Sun D; Tian B; Cheng A; Chen S
Microbiol Spectr; 2023 Feb; 11(1):e0292122. PubMed ID: 36625643
[TBL] [Abstract][Full Text] [Related]
19. Efficient inhibition of duck hepatitis B virus DNA by the CRISPR/Cas9 system.
Zheng Q; Bai L; Zheng S; Liu M; Zhang J; Wang T; Xu Z; Chen Y; Li J; Duan Z
Mol Med Rep; 2017 Nov; 16(5):7199-7204. PubMed ID: 28944845
[TBL] [Abstract][Full Text] [Related]
20. Transbody against virus core protein potently inhibits hepadnavirus replication in vivo: evidence from a duck model of hepatitis B virus.
Li Y; Liu Z; Hui L; Liu X; Feng A; Wang W; Zhang L; Li N; Zhou G; Wang Q; Han Q; Lv Y; Wang Q; Yang G; Wang Y
Br J Pharmacol; 2017 Jul; 174(14):2261-2272. PubMed ID: 28383135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
